Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of the novel HLA-DPA1*01:03:40 allele by sequencing-based typing. | HLA | 2022 | 35695196 | PubTator, text mining | PubMed |
| Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer. | Front Oncol | 2022 | 35692800 | PubTator, text mining | PubMed |
| MSLN Correlates With Immune Infiltration and Chemoresistance as a Prognostic Biomarker in Ovarian Cancer. | Front Oncol | 2022 | 35692779 | PubTator, text mining | PubMed |
| Comprehensive identification of RNA transcripts and construction of RNA network in chronic obstructive pulmonary disease. | Respir Res | 2022 | 35690768 | PubTator, text mining | PubMed |
| Principles of Virtual Crossmatch Testing for Kidney Transplantation. | Kidney Int Rep | 2022 | 35685330 | PubTator, text mining | PubMed |
| Construction of an HLA Classifier for Early Diagnosis, Prognosis, and Recognition of Immunosuppression in Sepsis by Multiple Transcriptome Datasets. | Front Physiol | 2022 | 35685286 | PubTator, text mining | PubMed |
| Molecular Markers of Kidney Transplantation Outcome: Current Omics Tools and Future Developments. | Int J Mol Sci | 2022 | 35682996 | PubTator, text mining | PubMed |
| Beyond GWAS-Could Genetic Differentiation within the Allograft Rejection Pathway Shape Natural Immunity to COVID-19? | Int J Mol Sci | 2022 | 35682950 | PubTator, text mining | PubMed |
| Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles. | Cell Rep | 2022 | 35675811 | PubTator, text mining | PubMed |
| Weighted Gene Co-Expression Network Analysis (WGCNA) Reveals the Functions of Syndecan-1 to Regulate Immune Infiltration by Influenced T Cells in Glioma. | Front Genet | 2022 | 35669186 | PubTator, text mining | PubMed |
| Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration. | World J Clin Cases | 2022 | 35665115 | PubTator, text mining | PubMed |
| Human Leukocyte Antigen (HLA) System: Genetics and Association with Bacterial and Viral Infections. | J Immunol Res | 2022 | 35664353 | PubTator, text mining | PubMed |
| A Potential Indicator ARRDC2 Has Feasibility to Evaluate Prognosis and Immune Microenvironment in Ovarian Cancer. | Front Genet | 2022 | 35664304 | PubTator, text mining | PubMed |
| Age-Related Adaptive Immune Changes in Parkinson's Disease. | J Parkinsons Dis | 2022 | 35661020 | PubTator, text mining | PubMed |
| MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy. | Oncoimmunology | 2022 | 35655709 | PubTator, text mining | PubMed |
| Comprehensive Analysis of PDLIM3 Expression Profile, Prognostic Value, and Correlations with Immune Infiltrates in Gastric Cancer. | J Immunol Res | 2022 | 35647201 | PubTator, text mining | PubMed |
| New Prognostic Gene Signature and Immune Escape Mechanisms of Bladder Cancer. | Front Cell Dev Biol | 2022 | 35646934 | PubTator, text mining | PubMed |
| Lestaurtinib Has the Potential to Inhibit the Proliferation of Hepatocellular Carcinoma Uncovered by Bioinformatics Analysis and Pharmacological Experiments. | Front Cell Dev Biol | 2022 | 35646925 | PubTator, text mining | PubMed |
| A panel of necroptosis-related genes predicts the prognosis of pancreatic adenocarcinoma. | Transl Oncol | 2022 | 35635957 | PubTator, text mining | PubMed |
| Immunopathogenic overlap between COVID-19 and tuberculosis identified from transcriptomic meta-analysis and human macrophage infection. | iScience | 2022 | 35634577 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=42